|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the SYT 6-K filed Feb 6, 2009. Europe, higher crop prices and
the elimination of the EU set-aside requirement resulted in increased acreage in
Western Europe. Strong demand for cereals favored the development of
the fungicide market in particular. Sales of AMISTAR®,
BRAVO® and our
leading triazole ALTO® all rose
by over 30 percent, illustrating the importance of a broad portfolio in the
treatment of disease, where resistance means that single compounds are often
ineffective. In Eastern Europe growth across all product lines
reflected the ongoing modernization of agriculture and the strengthening of our
market-leading position, a result of our long-standing presence in the region
and of recent investments in the product range and in marketing. In
|
| |||||||
